OPTION AGREEMENTOption Agreement • June 9th, 2023 • Humacyte, Inc. • Biological products, (no disgnostic substances) • New York
This OPTION AGREEMENT (this “Agreement”), is made and entered as of May 12, 2023 (the “Execution Date”), by and between (i) TPC INVESTMENTS III LP, a Delaware limited partnership, and TPC INVESTMENTS SOLUTIONS LP, a Delaware limited partnership (each, an “Investor” and collectively, the “Investors”) and (ii) HUMACYTE, INC., a Delaware corporation (the “Company”). The Investors and the Company are referred to herein, collectively, as the “Parties” and each, individually, as a “Party”.
